, director of the 汤头条 Vaccine Center at 汤头条 University Medical Center, led the team that discovered a monoclonal antibody combination that protects against COVID-19. Optimized and developed by AstraZeneca, the monoclonal antibody combination called鈥� is the first treatment to protect adults and children 12 years and older who have compromised immune systems before exposure to the virus.